C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.67 AUD
-1.76%
Market Closed
Updated:
May 15, 2024
Cyclopharm Ltd
Depreciation & Amortization
|
Cyclopharm Ltd
Depreciation & Amortization Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Depreciation & Amortization
-AU$938.8k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-4%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Depreciation & Amortization
-AU$1.5k
|
CAGR 3-Years
67%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Depreciation & Amortization
-AU$2.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-34%
|
|
|
Cochlear Ltd
ASX:COH
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Depreciation & Amortization
-AU$539.4k
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Depreciation & Amortization
-AU$342k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Depreciation & Amortization?
Depreciation & Amortization
-938.8k
AUD
-938.8k
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Depreciation & Amortization amounts to -938.8k AUD.
What is Cyclopharm Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-4%
-4%
Over the last year, the Depreciation & Amortization growth was -1%. The average annual Depreciation & Amortization growth rates for Cyclopharm Ltd have been -1% over the past three years , -13% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
